Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIVERIC bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/10/2023 | Q1 2023 | -$0.44 | -$0.52 | -0.08 | N/A | $0 |
| 03/01/2023 | Q4 2022 | -$0.37 | -$0.41 | -0.04 | N/A | $0 |
| 11/04/2022 | Q3 2022 | N/A | -$0.35 | N/A | N/A | $0 |
| 07/26/2022 | Q2 2022 | -$0.31 | -$0.40 | -0.09 | N/A | $0 |
| 05/04/2022 | Q1 2022 | -$0.29 | -$0.29 | 0 | N/A | $0 |
| 02/24/2022 | Q4 2021 | -$0.24 | -$0.29 | -0.05 | N/A | $0 |
| 11/09/2021 | Q3 2021 | -$0.29 | -$0.23 | 0.06 | N/A | $0 |
| 08/04/2021 | Q2 2021 | -$0.26 | -$0.32 | -0.06 | N/A | $0 |
| 05/05/2021 | Q1 2021 | -$0.27 | -$0.29 | -0.02 | N/A | $0 |
| 03/04/2021 | Q4 2020 | N/A | -$0.27 | N/A | N/A | $0 |
| 11/03/2020 | Q3 2020 | N/A | -$0.27 | N/A | N/A | $0 |
| 08/06/2020 | Q2 2020 | N/A | -$0.32 | N/A | N/A | $0 |
| 05/07/2020 | Q1 2020 | N/A | -$0.28 | N/A | N/A | $0 |
| 02/27/2020 | Q4 2019 | -$0.28 | -$0.39 | -0.11 | N/A | $0 |
| 11/12/2019 | Q3 2019 | N/A | -$0.35 | N/A | N/A | $0 |
| 08/01/2019 | Q2 2019 | N/A | -$0.35 | N/A | N/A | $0 |
| 05/08/2019 | Q1 2019 | -$0.36 | -$0.30 | 0.06 | N/A | $0 |
| 02/28/2019 | Q4 2018 | N/A | $2.62 | N/A | N/A | $0 |
| 11/02/2018 | Q3 2018 | N/A | -$0.41 | N/A | N/A | $0 |
| 08/01/2018 | Q2 2018 | -$0.39 | -$0.37 | 0.02 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
IVERIC bio, Inc. Earnings: FAQ's
IVERIC bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, July 23rd, 2023 based offlast year's report dates.
In the previous quarter, IVERIC bio, Inc. (:ISEE) reported $-0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.49 by $0.08.
The conference call for IVERIC bio, Inc.'s latest earnings report can be listened to online.
The conference call transcript for IVERIC bio, Inc.'s latest earnings report can be read online.
IVERIC bio, Inc. (:ISEE) has a recorded net income of $-175,745,000.IVERIC bio, Inc. has generated $-1.45 earnings per share over the last four quarters.
IVERIC bio, Inc. (:ISEE) has a price-to-earnings ratio of -27.51 and price/earnings-to-growth ratio is -0.28.